Protein Degradation and Inhibitors

9 та иш

Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms
Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4
МақолаProtein Degradation and InhibitorsBiomolecules20262 иқтибос
ABI
Mutational Profiling of Pediatric Myeloid Leukemia Subtypes without Clinically Significant Chromosomal Aberrations
Lilit Ghukasyan, George S. Krasnov, О. В. Муравенко +3
МақолаAcute Myeloid Leukemia ResearchMolecular Biology20191 иқтибос
ABI
createtls215citncateg.sql
European Patent Office
БошқаProtein Degradation and InhibitorsHarvard Dataverse20200 иқтибос
ABI
MAQOLA YOZAMAN SHE'RNI TO'XTATIB
Mulikboyev O'tkir Qo'chqor o'g'li, Soliyeva Dildora
МақолаSynthesis of β-Lactam CompoundsZenodo (CERN European Organization for Nuclear Research)20220 иқтибос
ABI
Flag-TBK1 N455S and Flag-TBK1 M559R cloning (NEB Site directed mutagenesis kit, #E0554S) v1
Jailyn Izu
ПрепринтUbiquitin and proteasome pathways20240 иқтибос
ABI
Alterations in 3D Chromatin Spatial Organisation in Tumourigenesis and Therapy Resistance of Glioblastoma: The Recent Advances in Understanding Molecular Mechanisms, Clinical Implications, and Therapeutic Perspectives
‎Anmar Ghanim Taki, Abdulkareem Shareef, Lalji Baldaniya +10
МақолаGenomics and Chromatin DynamicsClinical Oncology20250 иқтибос
ABI
AML-095: Loss of Sex Chromosome in Acute Myeloid Leukemia
Doskhan Orazkhanov, M Islamov, Zulkhumor Yunusova +1
МақолаAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia20250 иқтибос
ABI
Structure-driven design and precision translation of functionally diverse isatin-based CDK2 inhibitors: Advances in SAR, polypharmacology, and biomarker-guided cancer therapy
Safia Obaidur Rab, A. Al-Shahrani, Lalji Baldaniya +9
МақолаCancer-related Molecular PathwaysJournal of Molecular Structure20250 иқтибос
ABI
Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders
Haoran Lu, Zixiao Yang, Muzaffar Kayumov +7
МақолаProtein Degradation and InhibitorsACS Nano20260 иқтибос
ABI